Liver Disease

Study Evaluates Link Between Diet, Hepatic Health

November 20th 2021, 5:25pm


Findings from a cross-sectional study revealed a potential link between liver health and inflammatory diet properties.

Bariatric Surgery Reduced Risk of Major Adverse Liver, CV Outcomes in Patients With NASH

November 18th 2021, 10:30pm


Patients with nonalcoholic steatohepatitis (NASH) and obesity had a reduced risk of major adverse liver outcomes and major adverse cardiovascular (CV) events after they underwent bariatric surgery compared with patients who did not have surgery.

High Iron Levels in Blood Linked to Increased Risk of Liver Cancer in NAFLD

November 12th 2021, 1:00pm


Researchers conducted the study because although prior research has illustrated that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of liver cancer, little is known about the effect of this condition in nonalcoholic fatty liver disease (NAFLD).

NAFLD Is a Growing Driver of Chronic Liver Disease and Related Deaths

November 10th 2021, 3:30pm


An evaluation of data from the Global Burden of Disease found that nonalcoholic fatty liver disease (NAFLD) is a main driver of chronic liver disease and has increased among adolescents and young adults.

Children With HCC Have Higher Waitlist Mortality for Liver Transplant Than Children With HBL

November 5th 2021, 9:30pm


The higher waitlist mortality for liver transplant among children with hepatocellular carcinoma (HCC) compared with hepatoblastoma (HBL) indicates a need to improve prioritization for children with HCC.

Physical Activity Protects Against NAFLD, Study Suggests

October 30th 2021, 11:45pm


Inaugural Report Provides Insight Into Management and Trends of Chronic Liver Disease

October 27th 2021, 1:45pm


The incidence of chronic liver disease is expected to sharply rise by 2030, making it important to understand the factors that influence patient outcomes.

Outcomes and Mortality Risks in Patients With NAFLD

October 22nd 2021, 9:45pm


Mortality and liver-related complications increased with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD).

Tremelimumab Added to Durvalumab Shows Positive Results in HCC

October 15th 2021, 3:45pm


There was statistically significant and clinically meaningful overall survival benefit vs sorafenib as a first-line treatment for patients with unresectable hepatocellular carcinoma (HCC) in top-line results from a phase 3 trial.

Coffee Consumption Associated With Less Liver Stiffness

October 11th 2021, 9:30pm


Individuals who drink more than 3 cups of coffee a day had decreased liver stiffness.